NEWAMSTERDAM PHARMA COMPANY *W EXP 99/99/999 is a security (CUSIP N62509117) tracked across SEC portfolio filings. 12 institutional managers reported $27.4M on Form 13F as of 2026-03-31.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | MENLO PARK, CA | $10.0M | 500,333 |
| RA CAPITAL MANAGEMENT, L.P. | Boston, MA | $6.7M | 333,333 |
| Affinity Asset Advisors, LLC | New York, NY | $4.9M | 245,000 |
| Bain Capital Life Sciences Investors, LLC | Boston, MA | $2.0M | 99,999 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | New York, NY | $1.9M | 92,787 |
| MILLENNIUM MANAGEMENT LLC | NEW YORK, NY | $1.5M | — |
| ARISTEIA CAPITAL LLC | GREENWICH, CT | $343K | 15,708 |
| WOLVERINE ASSET MANAGEMENT LLC | CHICAGO, IL | $43K | 2,127 |
| CIBC Private Wealth Group, LLC | ATLANTA, GA | $25K | 1,000 |
| UBS Group AG | Zurich, V8 | $8K | 396 |
| Vestcor Inc | FREDERICTON, A3 | $131 | 6,666 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |